ArticleBMC research notes2025
Lack of association of the calpain-10 Indel-19 variant with chronic diseases in a Mexican population.
Article in BMC research notes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThe CAPN10 gene encodes a protein that regulates insulin secretion and glucose uptake. Its variant Indel-19 has been associated with an increased risk of type 2 diabetes mellitus, diabetes-related traits, and some chronic disorders, mainly obesity. This study aimed to investigate the association between the CAPN10 Indel-19 variant and some clinical parameters in a Mexican population sample. We recruited 426 apparently healthy individuals over 30 years of age. We obtained anthropometric data, arterial pressure, fasting biochemical parameters, and genotyping for CAPN10 Indel-19.
resultsThe frequency of overweight and obesity was 82.9%, hypertension 8%, hypercholesterolemia 14.8%, hypertriglyceridemia 31.9%, impaired plasma glucose 23.9%, and diabetes 4.7%. The genotype frequencies were 13.1%, 47.9%, and 39% for del/del, del/ins, and ins/ins, respectively; the allele frequencies were 37.1% for the del allele and 62.9% for the ins allele. The analysis of the continuous parameters according to the genotypes showed no significant differences. However, when these parameters were dichotomized (reference group versus high-level group), the ins allele was associated with a protective effect against high arterial pressure (prehypertension and hypertension). It is unclear whether the CAPN10 Indel-19 variant increases the risk of chronic diseases, so further studies are needed to confirm or refute this issue.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.